Resources
My Diabetes Care to Expect
Handy patient “business card” with checklists to track reviews, care processes and other appointments.
(Source: Diabetes UK)
At a glance: Diabetes and cancer
The potential links between diabetes and cancer, plus recommendations on management of hyperglycaemia in those undergoing cancer treatment. with checklists to track reviews, care processes and other appointments.
(Source: Diabetes & Primary Care)
How to undertake a multiple long-term conditions review
Delivery of holistic care to adults living with type 2 diabetes and one or more additional long-term conditions.
(Source: Diabetes & Primary Care)
Guidance
Interim commissioning guidance: implementation of the NICE technology appraisal TA1026 and the NICE funding variation for tirzepatide (Mounjaro®) for the management of obesity
NHS’s approach to implementing tirzepatide into the weight management pathway in England.
(Source: NHS England)
CPD
Type 2 Diabetes Prevention
Free module for healthcare professionals to understand what type 2 diabetes prevention is and how to support those at risk.
(Source: Diabetes UK)
Peer support
TAD (Talking About Diabetes) 2025
Free event in Liverpool for people living with type 1 diabetes and their partners/friends/carers, and healthcare professionals. Registration now open.
(Source: Talking About Diabetes)
Quick reads
Diabetes Distilled: Preserving muscle is important when using incretin mimetics for weight loss
Minimising loss of muscle mass when using GLP-1-based therapies for weight loss. [Open access]
(Source: Diabetes & Primary Care)
Diabetes Distilled: The 4S Pathway – realigning management for older people with diabetes
Practical guidance from the International Geriatric Diabetes Society on the management of diabetes in older people. [Open access]
(Source: Diabetes & Primary Care)
Changing the narrative: confronting diabetes-related stigma in healthcare
Editorial challenging healthcare professionals to prioritise compassionate communication in order to offer stigma-free support to patients. [Open access]
(Source: British Journal of Hospital Medicine)
Stigma, inequalities and early detection of type 1: DUKPC research highlights
A selection of recent exciting diabetes research developments.
(Source: Diabetes UK)
Journals: Articles
Analytical accuracy of a continuous glucose monitor in adult diabetic ketoacidosis
In adults with DKA, CGM can help measure blood glucose accurately and identify missed opportunities for intervention. [Open access]
(Source: CHEST Critical Care)
Simplified meal management in adults using an advanced hybrid closed-loop system
Simplified meal announcement strategies for those who face barriers to carbohydrate counting. [Open access]
(Source: Diabetes Technologies & Therapeutics)
Mobile Health Biometrics to Enhance Exercise and Physical Activity Adherence in Type 2 Diabetes (MOTIVATE-T2D): a decentralised feasibility randomised controlled trial delivered across the UK and Canada
Trial indicates that the MOTIVATE-T2D intervention is feasible and acceptable, with promising effects on adherence to purposeful exercise. [Open access]
(Source: BMJ Open)
Oral semaglutide and cardiovascular outcomes in high-risk type 2 diabetes
SOUL study finds improved cardiovascular outcomes compared to usual care in high-risk individuals. [Open access]
(Source: The New England Journal of Medicine)
Semaglutide and walking capacity in people with symptomatic peripheral artery disease and type 2 diabetes (STRIDE): a phase 3b, double-blind, randomised, placebo-controlled trial
STRIDE trial indicates semaglutide increases walking distance in patients with symptomatic PAD and type 2 diabetes.
(Source: The Lancet)
Glucagon-like peptide-1 receptor agonists and risk of suicidality among patients with type 2 diabetes: active comparator, new user cohort study
Investigation of the risk of suicidality associated with GLP-1 RA use compared with use of DPP-4 inhibitors and SGLT2 inhibitors. [Open access]
(Source: The British Medical Journal)
A five-drug class model using routinely available clinical features to optimise prescribing in type 2 diabetes: a prediction model development and validation study
Can routinely available clinical features be used to predict the relative glycaemic effectiveness of five glucose-lowering drug classes? [Open access]
(Source: The Lancet)
Intensive blood-pressure control in patients with type 2 diabetes
Intensive lowering of blood pressure may protect people with type 2 diabetes from heart disease. [Open access]
(Source: The New England Journal of Medicine)
Long-term frailty and physical performance transitions in older people with type-2 diabetes. The MIDFRAIL randomized clinical study
Multimodal intervention can reverse frailty status and slow down progression of frailty in older people with diabetes. [Open access]
(Source: The Journal of Nutrition, Health and Aging)
Risk of ischemic and hemorrhagic stroke in individuals with type 1 and type 2 diabetes: A nationwide cohort study in Sweden
Study findings highlight increased stroke risk in diabetes, with distinct patterns by stroke subtype and diabetes type. [Open access]
(Source: Neurology)
Impact of lipid-lowering combination therapy with statins and ezetimibe vs statin monotherapy on the reduction of cardiovascular outcomes: a meta-analysis
Large study suggests individuals at high risk of heart attacks and strokes should be treated immediately with a combination therapy. [Open access]
(Source: Mayo Clinic Proceedings)
Journal of
Diabetes Nursing
Issue:
Vol:29 | No:02
What’s hot in diabetes nursing? April 2025
Resources
My Diabetes Care to Expect
Handy patient “business card” with checklists to track reviews, care processes and other appointments.
(Source: Diabetes UK)
At a glance: Diabetes and cancer
The potential links between diabetes and cancer, plus recommendations on management of hyperglycaemia in those undergoing cancer treatment. with checklists to track reviews, care processes and other appointments.
(Source: Diabetes & Primary Care)
How to undertake a multiple long-term conditions review
Delivery of holistic care to adults living with type 2 diabetes and one or more additional long-term conditions.
(Source: Diabetes & Primary Care)
Guidance
Interim commissioning guidance: implementation of the NICE technology appraisal TA1026 and the NICE funding variation for tirzepatide (Mounjaro®) for the management of obesity
NHS’s approach to implementing tirzepatide into the weight management pathway in England.
(Source: NHS England)
CPD
Type 2 Diabetes Prevention
Free module for healthcare professionals to understand what type 2 diabetes prevention is and how to support those at risk.
(Source: Diabetes UK)
Peer support
TAD (Talking About Diabetes) 2025
Free event in Liverpool for people living with type 1 diabetes and their partners/friends/carers, and healthcare professionals. Registration now open.
(Source: Talking About Diabetes)
Quick reads
Diabetes Distilled: Preserving muscle is important when using incretin mimetics for weight loss
Minimising loss of muscle mass when using GLP-1-based therapies for weight loss. [Open access]
(Source: Diabetes & Primary Care)
Diabetes Distilled: The 4S Pathway – realigning management for older people with diabetes
Practical guidance from the International Geriatric Diabetes Society on the management of diabetes in older people. [Open access]
(Source: Diabetes & Primary Care)
Changing the narrative: confronting diabetes-related stigma in healthcare
Editorial challenging healthcare professionals to prioritise compassionate communication in order to offer stigma-free support to patients. [Open access]
(Source: British Journal of Hospital Medicine)
Stigma, inequalities and early detection of type 1: DUKPC research highlights
A selection of recent exciting diabetes research developments.
(Source: Diabetes UK)
Journals: Articles
Analytical accuracy of a continuous glucose monitor in adult diabetic ketoacidosis
In adults with DKA, CGM can help measure blood glucose accurately and identify missed opportunities for intervention. [Open access]
(Source: CHEST Critical Care)
Simplified meal management in adults using an advanced hybrid closed-loop system
Simplified meal announcement strategies for those who face barriers to carbohydrate counting. [Open access]
(Source: Diabetes Technologies & Therapeutics)
Mobile Health Biometrics to Enhance Exercise and Physical Activity Adherence in Type 2 Diabetes (MOTIVATE-T2D): a decentralised feasibility randomised controlled trial delivered across the UK and Canada
Trial indicates that the MOTIVATE-T2D intervention is feasible and acceptable, with promising effects on adherence to purposeful exercise. [Open access]
(Source: BMJ Open)
Oral semaglutide and cardiovascular outcomes in high-risk type 2 diabetes
SOUL study finds improved cardiovascular outcomes compared to usual care in high-risk individuals. [Open access]
(Source: The New England Journal of Medicine)
Semaglutide and walking capacity in people with symptomatic peripheral artery disease and type 2 diabetes (STRIDE): a phase 3b, double-blind, randomised, placebo-controlled trial
STRIDE trial indicates semaglutide increases walking distance in patients with symptomatic PAD and type 2 diabetes.
(Source: The Lancet)
Glucagon-like peptide-1 receptor agonists and risk of suicidality among patients with type 2 diabetes: active comparator, new user cohort study
Investigation of the risk of suicidality associated with GLP-1 RA use compared with use of DPP-4 inhibitors and SGLT2 inhibitors. [Open access]
(Source: The British Medical Journal)
A five-drug class model using routinely available clinical features to optimise prescribing in type 2 diabetes: a prediction model development and validation study
Can routinely available clinical features be used to predict the relative glycaemic effectiveness of five glucose-lowering drug classes? [Open access]
(Source: The Lancet)
Intensive blood-pressure control in patients with type 2 diabetes
Intensive lowering of blood pressure may protect people with type 2 diabetes from heart disease. [Open access]
(Source: The New England Journal of Medicine)
Long-term frailty and physical performance transitions in older people with type-2 diabetes. The MIDFRAIL randomized clinical study
Multimodal intervention can reverse frailty status and slow down progression of frailty in older people with diabetes. [Open access]
(Source: The Journal of Nutrition, Health and Aging)
Risk of ischemic and hemorrhagic stroke in individuals with type 1 and type 2 diabetes: A nationwide cohort study in Sweden
Study findings highlight increased stroke risk in diabetes, with distinct patterns by stroke subtype and diabetes type. [Open access]
(Source: Neurology)
Impact of lipid-lowering combination therapy with statins and ezetimibe vs statin monotherapy on the reduction of cardiovascular outcomes: a meta-analysis
Large study suggests individuals at high risk of heart attacks and strokes should be treated immediately with a combination therapy. [Open access]
(Source: Mayo Clinic Proceedings)
Latest news: tirzepatide prescribing for obesity, AI predicting kidney disease, and recognition of type 5 diabetes
Tirzepatide roll out for obesity clearer, but questions remain
Malnutrition-related diabetes formally recognised after years of debate
What’s hot in diabetes nursing? April 2025
A tribute to June James
The impact of wearable diabetes technology on sexual activity
Diabetic kidney disease: Part 1 – pathology, prevalence, risk factors, problems, screening and monitoring
Developments that will impact your practice.
7 May 2025
Su Down examines the tirzepatide plans and their implications for primary care.
1 May 2025
International Diabetes Federation officially recognises “type 5 diabetes”, decades after first being observed.
24 Apr 2025
Su Down and Debbie Hicks pay tribute to the late June James.
14 Apr 2025